Dan Theodorescu

30.2k total citations · 4 hit papers
335 papers, 14.6k citations indexed

About

Dan Theodorescu is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dan Theodorescu has authored 335 papers receiving a total of 14.6k indexed citations (citations by other indexed papers that have themselves been cited), including 154 papers in Molecular Biology, 133 papers in Surgery and 107 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dan Theodorescu's work include Bladder and Urothelial Cancer Treatments (111 papers), Prostate Cancer Diagnosis and Treatment (46 papers) and Prostate Cancer Treatment and Research (46 papers). Dan Theodorescu is often cited by papers focused on Bladder and Urothelial Cancer Treatments (111 papers), Prostate Cancer Diagnosis and Treatment (46 papers) and Prostate Cancer Treatment and Research (46 papers). Dan Theodorescu collaborates with scholars based in United States, Canada and Germany. Dan Theodorescu's co-authors include Henry F. Frierson, Steven C. Smith, Michael A. Harding, Mark R. Conaway, Charles R. Owens, Jason E. Duex, Gary Oxford, Garrett M. Dancik, Garret M. Hampton and Patricia S. Steeg and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Dan Theodorescu

325 papers receiving 14.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The multiMiR R package and database: integration of microRNA–target interactions along with their disease and drug associations

2014 475 citations Yuanbin Ru, Dan Theodorescu et al. profile →
Advances in bladder cancer biology and therapy

2020 456 citations Neeraj Agarwal, Jason E. Duex et al. profile →
Bladder cancer

2023 212 citations Donna E. Hansel, Dan Theodorescu et al. profile →
Y chromosome loss in cancer drives growth by evasion of adaptive immunity

2023 94 citations Dan Theodorescu et al. profile →

Peers

Countries citing papers authored by Dan Theodorescu

Since Specialization

Citations

This map shows the geographic impact of Dan Theodorescu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Theodorescu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Theodorescu more than expected).

Fields of papers citing papers by Dan Theodorescu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Theodorescu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Theodorescu. The network helps show where Dan Theodorescu may publish in the future.

Co-authorship network of co-authors of Dan Theodorescu

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Theodorescu. A scholar is included among the top collaborators of Dan Theodorescu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Theodorescu. Dan Theodorescu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Correlative Analysis of ATM, RB1, ERCC2, and FANCC Mutations and Pathologic Complete Response After Neoadjuvant Chemotherapy in Patients with Muscle-invasive Bladder Cancer: Results from the SWOG S1314 Trial 2024 ·European Urology ·Elizabeth R. Plimack, Catherine M. Tangen, Melissa Plets, (unknown), Joanne Xiu, Chadi Nabhan, Eric A. Ross, (unknown), Woonyoung Choi, (unknown), (unknown), (unknown), M. Scott Lucia, Siamak Daneshmand, Dan Theodorescu, Amir Goldkorn, Seth P. Lerner, Thomas W. Flaig, David J. McConkey	7
2	A Randomized Phase II Study of Coexpression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Bladder Cancer (SWOG S1314; NCT02177695) 2021 ·Clinical Cancer Research ·Thomas W. Flaig, Catherine M. Tangen, Siamak Daneshmand, Ajjai Alva, Seth P. Lerner, M. Scott Lucia, David J. McConkey, Dan Theodorescu, Amir Goldkorn, Matthew I. Milowsky, Rick Bangs, Gary R. MacVicar, Bruno R. Bastos, Jared S. Fowles, Daniel L. Gustafson, Melissa Plets, Ian M. Thompson	58
3	Androgen Receptor Regulates CD44 Expression in Bladder Cancer 2021 ·Cancer Research ·Joseph L. Sottnik, Lauren A. Vanderlinden, Molishree Joshi, (unknown), Charles R. Owens, Donna E. Hansel, (unknown), Debashis Ghosh, Dan Theodorescu	32
4	Nuclear CD24 Drives Tumor Growth and Is Predictive of Poor Patient Prognosis 2017 ·Cancer Research ·Jason E. Duex, Charles R. Owens, (unknown), Garrett M. Dancik, Lauren A. Vanderlinden, Debashis Ghosh, (unknown), Donna E. Hansel, Dan Theodorescu	22
5	GON4L Drives Cancer Growth through a YY1–Androgen Receptor–CD24 Axis 2016 ·Cancer Research ·Neeraj Agarwal, Garrett M. Dancik, Andrew Goodspeed, James C. Costello, Charles R. Owens, Jason E. Duex, Dan Theodorescu	42
6	Loss of Glycogen Debranching Enzyme AGL Drives Bladder Tumor Growth via Induction of Hyaluronic Acid Synthesis 2015 ·Clinical Cancer Research ·Sunny Guin, Yuanbin Ru, Neeraj Agarwal, Carolyn R. Lew, Charles R. Owens, Giacomo P. Comi, Dan Theodorescu	24
7	Patient Mutation Directed shRNA Screen Uncovers Novel Bladder Tumor Growth Suppressors 2015 ·Molecular Cancer Research ·Jonathan A. Hensel, Jason E. Duex, Charles R. Owens, Garrett M. Dancik, Michael G. Edwards, Henry F. Frierson, Dan Theodorescu	25
8	RhoC Is an Unexpected Target of RhoGDI2 in Prevention of Lung Colonization of Bladder Cancer 2014 ·Molecular Cancer Research ·Erin Griner, Garrett M. Dancik, James C. Costello, Charles R. Owens, Sunny Guin, Michael G. Edwards, David L. Brautigan, Dan Theodorescu	15
9	Concurrent Alterations in TERT , KDM6A , and the BRCA Pathway in Bladder Cancer 2014 ·Clinical Cancer Research ·Michael L. Nickerson, Garrett M. Dancik, Kate M. Im, Michael G. Edwards, Sevilay Turan, Joseph Brown, (unknown), Charles R. Owens, James C. Costello, Guangwu Guo, Shirley Tsang, Yingrui Li, Quan Zhou, Zhiming Cai, Lee E. Moore, M. Scott Lucia, Michael Dean, Dan Theodorescu	87
10	Translation Initiation Factor eIF3b Expression in Human Cancer and Its Role in Tumor Growth and Lung Colonization 2013 ·Clinical Cancer Research ·Hong Wang, Yuanbin Ru, Marta Sänchez‐Carbayo, Xuejiao Wang, Jeffrey S. Kieft, Dan Theodorescu	68
11	Transcriptional Signatures of Ral GTPase Are Associated with Aggressive Clinicopathologic Characteristics in Human Cancer 2012 ·Cancer Research ·Steven C. Smith, Alexander S. Baras, Charles R. Owens, Garrett M. Dancik, Dan Theodorescu	33
12	CD24 Is an Effector of HIF-1–Driven Primary Tumor Growth and Metastasis 2012 ·Cancer Research ·Shibu Thomas, Michael A. Harding, Steven C. Smith, Jonathan B. Overdevest, Matthew D. Nitz, Henry F. Frierson, Scott A. Tomlins, Glen Kristiansen, Dan Theodorescu	117
13	CD24 Offers a Therapeutic Target for Control of Bladder Cancer Metastasis Based on a Requirement for Lung Colonization 2011 ·Cancer Research ·Jonathan B. Overdevest, Shibu Thomas, Glen Kristiansen, Donna E. Hansel, Steven C. Smith, Dan Theodorescu	97
14	A Framework to Select Clinically Relevant Cancer Cell Lines for Investigation by Establishing Their Molecular Similarity with Primary Human Cancers 2011 ·Cancer Research ·Garrett M. Dancik, Yuanbin Ru, Charles R. Owens, Dan Theodorescu	21
15	Prospective Comparison of Clinical and Genomic Multivariate Predictors of Response to Neoadjuvant Chemotherapy in Breast Cancer 2010 ·Clinical Cancer Research ·Jae K. Lee, Charles Coutant, Young Chul Kim, Yuan Qi, Dan Theodorescu, W. Fraser Symmans, Keith Baggerly, Roman Rouzier, Lajos Pusztai	60
16	Phosphorylation of RalB Is Important for Bladder Cancer Cell Growth and Metastasis 2010 ·Cancer Research ·Hong Wang, Charles R. Owens, (unknown), Mark R. Conaway, David L. Brautigan, Dan Theodorescu	48
17	Src and Caveolin-1 Reciprocally Regulate Metastasis via a Common Downstream Signaling Pathway in Bladder Cancer 2010 ·Cancer Research ·Shibu Thomas, Jonathan B. Overdevest, Matthew D. Nitz, Paul D. Williams, Charles R. Owens, Marta Sänchez‐Carbayo, Henry F. Frierson, Martin A. Schwartz, Dan Theodorescu	79
18	Prediction of Muscle-invasive Bladder Cancer Using Urinary Proteomics 2009 ·Clinical Cancer Research ·Eric Schiffer, Antonia Vlahou, Andreas Petrolekas, Konstantinos Stravodimos, Robert Tauber, (unknown), Jochen Neuhaus, Jens‐Uwe Stolzenburg, Mark R. Conaway, Harald Mischak, Dan Theodorescu	82
19	Src phosphorylation of RhoGDI2 regulates its metastasis suppressor function 2009 ·Proceedings of the National Academy of Sciences ·Yimin Wu, Konstadinos Moissoglu, Hong Wang, Xuejiao Wang, Henry F. Frierson, Martin A. Schwartz, Dan Theodorescu	61
20	Rho GDP Dissociation Inhibitor 2 Suppresses Metastasis via Unconventional Regulation of RhoGTPases 2009 ·Cancer Research ·Konstadinos Moissoglu, (unknown), Jeremy A. Meier, Dan Theodorescu, Martin A. Schwartz	62

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact